- Home
- About AfroCAB
- Community representatives
- Contact AfroCAB
- Membership terms
- AfroCAB documents and policies
- Administration
- Appeals
- Guidelines writing groups – background
- Community representation
- Copyright policy
- Disclaimer
- Governance
- Meeting organisation
- Membership terms
- Privacy policy
- AfroCAB message board user agreement and posting rules
- AfroCAB representation at pharmaceutical company Community Advisory Boards
- AfroCAB Funders
- AfroCAB executive steering committee
- Contact AfroCAB
- Join the AfroCAB
- Meetings
- Message Boards
- Message boards user guide
- Attaching a document
- Buttons and features
- Changing your email address
- Communicating with other members
- Getting messages by email
- Managing your personal details
- Message board jargon
- Printing messages
- Privacy and confidentiality
- Reading messages
- Setting a password reminder
- Signing in to the message boards
- Writing messages
- Resources
- AfroCAB members
-
Membership of AfroCAB is free and open to HIV-positive people and community advocates.
Pages
- Home
- AfroCAB activities by country
- AFROCAB members at INTEREST conference
- @afrocab_hiv and #TAG are excited to share a call for a new cross-disease long-acting technologies (LAT) community advisory board (CAB) focused on #malaria, the #HepC virus and #LTBI for a 4year tenure, 2021-2024. Deadline 1st June 2021!
- Board Members
- About AfroCAB
- Contact AfroCAB
- Join the AfroCAB
- Meetings
- Resources
- AfroCAB members